|
|
|
Conversations at EHA 2008: The IMF Interviews
|
|
|
|
|
This was the third conference this spring we attended with Dr Ludwig: The IMF Scientific Advisory Board Meeting, ASCO, and EHA (European Hematology Association) where we conducted this interview. Based on these meetings, Dr Ludwig had some important points to make... |
|
|
|
|
We spoke to Dr. Hájek, chairman of the Czech Myeloma Group, about what he sees as the major advances in myeloma treatment based on this conference (EHA) and ASCO, which just concluded. The first of his two key points is his concern that studies of new drug combinations may not be cost effective for myeloma patients in his country. |
|
|
back
print
back to top